Parasitic Ulcer Treatment Trial (PUTT)

PUTT Logo

About the Study

Acanthamoeba corneal infections are difficult to treat and often require eyedrops for 6–12 months or longer. There is no clear consensus on the best treatment approach.Some doctors believe steroid eyedrops may help reduce inflammation and improve vision, while others worry steroids might prolong the infection. This study aims to find out whether steroid eyedrops are safe and effective when used to treat acanthamoeba infections.

What's Involved

  Eligibility Criteria

  • Age 8 years or older, except for 16 years or older in the UK
  • Diagnosed with acanthamoeba keratitis (AK) confirmed by lab testing or confocal microscopy
  • Ocular inflammation after 1 month of anti-amoeba treatment

   Cannot join if you have:

  • Herpetic or fungal keratitis
  • Corneal perforation or prior corneal transplant for AK
  • No light perception vision in the affected eye
  • Allergy or hypertensive reaction to corticosteroids
  • Currently taking systemic corticosteroids

   A study doctor will confirm eligibility during screening.

  Required Visits and Procedures

  • You will use an eyedrop for acanthamoeba for 1 month.
  • After that, if still eligible, you’ll be randomized (like a coin flip) to receive either a steroid eyedrop or a lubricating eyedrop.
  • You’ll take this study eyedrop for 2 months while continuing the anti-amoebic eyedrop.
  • Follow-up visits: 1 month, 6 weeks, 2 months, 3 months, 6 months, and 12 months.
  • Each visit lasts about 2 hours and includes eye imaging and vision testing.

  Possible Benefits

  • Free anti-amoeba medication (normally not covered by insurance)
  • Access to an effective eyedrop, not yet available in the U.S.
  • Close monitoring with advanced imaging by experienced ophthalmologists
  • Helping future patients by contributing to better treatment research

Learn More

📄 View the Patient Information Sheet (PDF)
🔗 View study details on ClinicalTrials.gov

 Contact the UCSF Study Team

  For more information, contact your nearest enrollment center or the coordinating center (UCSF).

     Dr. Jeremy Keenan, MD MPH
     UCSF Department of Ophthalmology, Proctor Foundation
     📧 [email protected]
     ☎️ (415) 476-6323

     Dr. Gerami Seitzman, MD
     UCSF Department of Ophthalmology, Proctor Foundation
     📧 [email protected]
     ☎️ (415) 476-1442

Enrollment Centers

 

Site Information

InstitutionSite InvestigatorsContact InformationCityCountry
University of California, San FranciscoJeremy Keenan MD
Gerami Seitzman MD

[email protected]

[email protected]

San FranciscoUSA
Oregon Health & Science UniversityRoma Pegany MD[email protected] PortlandUSA
University of Illinois, ChicagoElmer Tu MD
Maria Soledad Cortina MD

[email protected]

[email protected]

ChicagoUSA
University of FloridaSonal Tuli MD[email protected]GainesvilleUSA
University of PittsburghGaurav Prakash MD[email protected]PittsburghUSA
University of MiamiGuillermo Amescua MD[email protected]MiamiUSA
Columbia UniversityLeejee Suh MD[email protected]New YorkUSA
University of PennsylvaniaBennie Jeng MD[email protected]PhiladelphiaUSA
Johns Hopkins UniversityNakul Shekhawat MD[email protected]BaltimoreUSA
University of IowaMark Greiner MD[email protected]Iowa CityUSA
University of WashingtonMinh Nguyen MD[email protected]SeattleUSA
Baylor College of MedicineAlejandro Arboleda MD[email protected]HoustonUSA
Universidade Federal de Sao PauloDenise de Freitas MD[email protected]São PauloBrazil
Aravind Eye Care System - MaduraiN. Venkatesh Prajna MD[email protected]Madurai India
Aravind Eye Care System - CoimbatoreRevathi Rajamaran[email protected] CoimbatoreIndia
Moorfields Eye HospitalSu-yin Koay MD[email protected]LondonEngland

The study in this website was supported by the National Eye Institute of the National Institutes of Health under Award Number UG1EY033284. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.